Glycohemoglobin analyzer A1C EZ 2.0
Performance | Technical characteristics |
Principal | Boronate affinity chromatography |
Item of test | Glycohemoglobin (Hb1Ac) |
Range of test | 4.0%~14.0% |
Sample requirements | Capillary blood or venous blood (EDTA anticoagulant) |
Sample volume | about 3µL |
Testing time | 6 ±1 minut |
Indicators of result | Preset display index: NGSP metric%; IFCC Metric mmol / Mole, Shift of Mean Blood Glucose Display (eAG) Metric mmol / L (mg / dl) in Test Mode |
Voice promt | Voice prompt in all work processes (when the voice is set to “ON” mode) |
Memory | 1000 tests |
Data ports | Mini USB port (can be connected to HIS / LIS system, thermal printer) |
Power source | 6.0V (-), 4 Batteries AAA |
Battery life | 1000 tests |
Factory calibration | Calibration is not required during use |
Correction of temperature | Using a temperature sensor for automatic correction |
Dimension (mm) | 122.6mm x 61.0mm x 24.5mm |
Display size | 52.0mm x 39.4mm |
Weight | 112 г (without batteries) |
Operating conditions | Temperature10 ~ 40 ° C; Humidity3Q% ~ 75% |
Storage conditions | Temperature : -20 ~ 55 ° C, Humidity <80% |
Glycohemoglobin analyzerA1C EZ 2.0 is designed to determine the concentration of glycohemoglobin (HbA1c) in human blood.
Small weight and size of the device.
- Works both with venous blood and capillary blood from the finger (3 μl of whole blood will be needed (1 large drop)).
- The result in 5 minutes.
- The study does not require the delivery of blood on an empty stomach or a special diet.
- Easy operation of the device and no complicated test procedure.
- This product meets the requirements of the directive 98/79 / EC for diagnosis “in vitro.
The level of HbA1c (glycated hemoglobin) is determined in the A1C EZ 2.0 analyzer by the method of boron affinity, which was deservedly recognized among specialists in this field. According to the requirements of the World Standards, the analyzer A1C EZ 2.0 is standardized and passes annual certification in the IFCC (International Federation of Clinical Chemistry) and NGSP (the national program for the standardization of glycated hemoglobin, USA), which is an indicator of the high quality and accuracy of the results obtained, and also allows its use in clinical practice.
Difficulties in diagnosing and controlling the quality of diabetes treatment required the development of new indicators and laboratory methods. This indicator was the level of glycohemoglobin or HbA1c. Glycohemoglobin (HbA1C) is a form of hemoglobin that forms when it interacts with glucose in the blood. The amount of HbA1C directly depends on the level of glucose, and for the lifetime of the erythrocyte, that is, you can find the average level of glycemia in about 90-120 days, respectively, before this study. The rate of formation of glycosylated hemoglobin depends on the severity of glycemia, and its decrease and / or normalization occurs within 4-6 weeks after reaching normal blood glucose values. These properties have enabled the World Health Organization since 2002. recommend the determination of the amount of glycated hemoglobin to all people with diabetes every 3 months. It should be specially noted that the level of HbA1C does not depend on the time of day, nor on the intake of food, nor on the level of physical exertion, nor on the emotional state of the subject.
Difficulties in diagnosing and controlling the quality of diabetes treatment required the development of new indicators and laboratory methods. This indicator was the level of glycohemoglobin or HbA1c.
Glycated hemoglobin (HbA1C) is a form of hemoglobin that forms when it interacts with glucose in the blood. The amount of HbA1C directly depends on the level of glucose, and for the lifetime of the erythrocyte, that is, you can find the average level of glycemia in about 90-120 days, respectively, before this study. The rate of formation of glycosylated hemoglobin depends on the severity of glycemia, and its decrease and / or normalization occurs within 4-6 weeks after reaching normal blood glucose values. These properties have enabled the World Health Organization since 2002. recommend the determination of the amount of glycated hemoglobin to all people with diabetes every 3 months. It should be specially noted that the level of HbA1C does not depend on the time of day, nor on the intake of food, nor on the level of physical exertion, nor on the emotional state of the subject.